+Search query
-Structure paper
Title | Crystallographic Analysis Reveals that Anticancer Clinical Candidate L-778,123 Inhibits Protein Farnesyltransferase and Geranylgeranyltransferase-I by Different Binding Modes. |
---|---|
Journal, issue, pages | Biochemistry, Vol. 43, Page 9000-9008, Year 2004 |
Publish date | Jan 22, 2004 (structure data deposition date) |
![]() | Reid, T.S. / Long, S.B. / Beese, L.S. |
![]() | ![]() ![]() |
Methods | X-ray diffraction |
Resolution | 1.9 - 2.55 Å |
Structure data | ![]() PDB-1s63: ![]() PDB-1s64: |
Chemicals | ![]() ChemComp-ZN: ![]() ChemComp-FPP: ![]() ChemComp-778: ![]() ChemComp-HOH: ![]() ChemComp-SO4: ![]() ChemComp-MES: ![]() ChemComp-CL: |
Source |
|
![]() | TRANSFERASE / FARNESYLTRANSFERASE / FTASE / GERANYLGERANYLTRANSFERASE / CANCER / CAAX / FTI / INHIBITOR / RAS / LIPID MODIFICATION / PROTEIN PRENYLATION / L-778 / 123 / protein geranylgeranyltransferase type-I / drug |